about
Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motilityCandidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells.Roles for the type III TGF-beta receptor in human cancerVasectomy and risk of aggressive prostate cancer: a 24-year follow-up study.Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.Roles of prohibitin in growth control and tumor suppression in human cancersA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma.TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.Transcriptional profiling analysis and functional prediction of long noncoding RNAs in cancer.miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue.Combating immunosuppression in gliomaElevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancerAxl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.Proteoglycans in prostate cancer.Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinomaThe extracellular domain of the TGFbeta type II receptor regulates membrane raft partitioning.Vasectomy: potential links to an increased risk of aggressive prostate cancer?Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.Profiling Prostate Cancer Therapeutic Resistance.Mechanisms navigating the TGF-β pathway in prostate cancer.Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas.Dysregulation of betaglycan expression in primary human endometrial carcinomas.[Defective expression of TGFBR3 gene and its molecular mechanisms in non-small cell lung cancer cell lines].
P2860
Q28594979-D40B752E-23A0-4EC2-B86F-ED3B48ED28E5Q33490254-1ED06483-F5D6-4FCA-9C03-6DA13FCF3006Q33642461-E45A9E28-477E-4522-A3A0-7A401CCFEEDFQ33872593-E4AD9BF6-3D60-4188-B031-945A0C2995B9Q34172049-83765C43-5EA2-426D-8FA4-27CD42BA7E0BQ34382586-BF2103F0-F6F1-4577-86DE-51D5E60D6192Q34497715-A43DDD24-3EEC-44BA-8BA9-6D2880E963F7Q35281526-4F3290D4-297D-4B3B-A621-8B2DFE0E37D4Q35562945-35591839-29BC-4799-B8FF-62F810E31292Q36946733-4089627A-30AF-44B7-8D9F-EC3D0B3DFE1DQ37157776-88DB1FC7-FABE-4F65-AD79-50859F2BB9D0Q37179415-D2764947-719F-46A9-9DE6-5876BD101738Q37225724-07808DDC-C5FA-4F53-9D54-E75E11FB6876Q37397455-5A1F6EDF-FC23-468B-BAD8-9F4545841982Q37475741-AF5DABB9-913B-4BD7-A576-A8A82E902FB6Q37735525-2291B836-644D-473F-A0D0-26958F90FF86Q37986399-54CDF0D0-D0DA-4362-BE63-F3EE070CDF0FQ38345995-DBF442AD-C5A2-4410-8602-A6D6C9202A84Q39862772-48CD1BBB-BF54-4AFE-88DB-A5054572499CQ40506794-4B537398-D601-4F62-BC26-4AB6DE16FFF7Q42396664-128F5A58-085D-43EF-8FEC-4D4D66A373E6Q47410403-65FE643F-747A-4939-880C-7462D7FBC9C9Q52644478-7EC44D05-6659-4D4B-A67E-EB9BF293073CQ54299380-25EDE613-9F88-44C1-AF18-4EB028AE6778Q54410492-04AEFC36-816F-4FC4-83D1-246B12A6D979Q54618088-B2AC35AB-B6F3-4E6B-9445-8F28CCE74A10Q55437517-4457B379-ACD4-4F56-A12B-AC9294E404C3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
TGFBR3 loss and consequences in prostate cancer.
@en
type
label
TGFBR3 loss and consequences in prostate cancer.
@en
prefLabel
TGFBR3 loss and consequences in prostate cancer.
@en
P2093
P356
P1433
P1476
TGFBR3 loss and consequences in prostate cancer.
@en
P2093
Brian T Kawasaki
Elaine M Hurt
Nima Sharifi
William L Farrar
P304
P356
10.1002/PROS.20526
P577
2007-02-01T00:00:00Z